Topic: biomanufacturing

Cambridge, MA, and Boston

Moderna to plow $110M into manufacturing build-out

To any other private biotech, sinking $110 million into a custom-built manufacturing facility while its most advanced programs are in Phase II would be unthinkable. But not for Moderna, a prominent Cambridge, MA-based startup that’s deep into so-called unicorn territory with a reported valuation of $5 billion.